Clinical trials and Haemophilia during the COVID-19' pandemic: Madrid's Experience

ABSTRACT

In times of crisis, continuous adaptation is necessary. Communication between all members of a research team is key to adapting the development of clinical trials to the context of the epidemiological crisis of coronavirus. We are accustomed to performing day-to-day tasks to fulfil protocol requirements with precision. To this end, we typically have had protocol-guided face-to-face visits and we have followed a detailed sequenced procedure during each visit.